From IMI to IHI - We have a new name. Find out why, and what else has changed…

Why we're changing

Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 9 projects/programmes

c4c

conect4children - Collaborative network for European clinical trials for children

Ongoing IMI2 Clinical trial design Clinical networks Patient involvement in R&D Tools for pediatrics

COMBACTE-CDI

Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

Closed IMI2 Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Clinical networks Real-world data, evidence

COMBACTE-MAGNET

Combatting bacterial resistance in Europe - molecules against Gram negative infections

Ongoing IMI1 Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks

COMBACTE-NET

Combatting Bacterial Resistance in Europe

Ongoing IMI1 Antimicrobial resistance Infectious diseases ND4BB Clinical networks

EPND

European Platform for Neurodegenerative Diseases

Ongoing IMI2 Neurodegenerative diseases Alzheimer's disease Tools for predicting/monitoring efficacy Biobanks Clinical networks Big data and knowledge management

EU-PEARL

EU patient-centric clinical trial platform

Ongoing IMI2 Diabetes & metabolic disorders Psychiatric diseases Infectious diseases Rare/orphan diseases Clinical trial design Clinical networks Patient involvement in R&D

HIPPOCRATES

Health initiatives in psoriasis and psoriatic arthritis consortium European states

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Clinical networks Disease taxonomy Artificial intelligence

iABC

Inhaled antibiotics in bronchiectasis and cystic fibrosis

Ongoing IMI1 Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Biobanks Clinical networks Drug delivery

ND4BB

New Drugs for Bad Bugs

Ongoing IMI1 Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks Real-world data, evidence Drug discovery Economic model